| Company Name: |
LGM Pharma |
| Tel: |
1-(800)-881-8210 |
| Email: |
inquiries@lgmpharma.com |
| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
- Nefazodone
-
- $35.00
-
2026-07-27
- CAS:83366-66-9
- Purity: 99.85%
- Supply Ability: 10g
- Nefazodone
-
- $1.00
-
2019-07-06
- CAS:83366-66-9
- Min. Order: 1G
- Purity: 98%
- Supply Ability: 100KG
|
| | Nefazodone Basic information |
| Product Name: | Nefazodone | | Synonyms: | 3h-1,2,4-triazol-3-one,2,4-dihydro-2-3-(4-(3-chlorophenyl)-1-piperazinyl)propy;l)-5-ethyl-4-(2-phenoxyethyl)-;BMY-13754;SERZONE;MJ-13754-1;NEFAZODONE;2-[3-[4-(3-CHLOROPHENYL)-1-PIPERAZINYL]PROPYL]-5-ETHYL-2,4-DIHYDRO-4-(2-PHENOXYETHYL)-3H-1,2,4-TRIAZOL-3-ONE HYDROCHLORIDE;Nefazodone base | | CAS: | 83366-66-9 | | MF: | C25H32ClN5O2 | | MW: | 470.01 | | EINECS: | | | Product Categories: | API;Intermediates & Fine Chemicals;Pharmaceuticals | | Mol File: | 83366-66-9.mol |  |
| | Nefazodone Chemical Properties |
| Melting point | 180-182°C | | Boiling point | 599.6±60.0 °C(Predicted) | | density | 1.23±0.1 g/cm3(Predicted) | | storage temp. | 2-8°C | | solubility | DMSO: ~11 mg/mL at 60 °C | | form | solid | | pka | pKa 6.5 (Uncertain) | | color | white | | CAS DataBase Reference | 83366-66-9(CAS DataBase Reference) | | NIST Chemistry Reference | Nefazodone(83366-66-9) |
| | Nefazodone Usage And Synthesis |
| Chemical Properties | Crystalline Solid | | Originator | Dutonin,Bristol-Myers Squibb,USA | | Uses | A selective serotonin 5-HT2 receptor antagonist. An antidepressant | | Definition | ChEBI: Nefazodone is a N-arylpiperazine, a N-alkylpiperazine, a member of triazoles, a member of monochlorobenzenes and an aromatic ether. It has a role as an antidepressant, a serotonergic antagonist, a serotonin uptake inhibitor, an alpha-adrenergic antagonist and an analgesic. | | Brand name | Serzone (Bristol-Myers Squibb). | | Therapeutic Function | Antidepressant | | Biological Functions | Although nefazodone (Serzone) is structurally related
to trazodone, it is less sedating. It does not block α1-
adrenoreceptors, and its use is not associated with priapism.
Nefazodone inhibits the neuronal reuptake of
serotonin and blocks 5HT2A receptors. Its short half-life
requires dosing twice a day. Nefazodone is
not associated with weight gain or sexual dysfunction. It
inhibits the cytochrome P450 3A4 isoenzyme that is responsible
for 50% of known oxidative metabolism, and
therefore, nefazodone can elevate levels of drugs dependent
on this pathway for metabolism. |
| | Nefazodone Preparation Products And Raw materials |
|